Get the latest Science News and Discoveries

Dana-Farber research supports FDA approval of pembrolizumab-belzutifan combination for higher-risk clear cell kidney cancer after surgery - EurekAlert!

Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of FDA

FDA

Photo of Dana-Farber

Dana-Farber

Photo of FDA approval

FDA approval

Related news:

FDA Approves First New Sunscreen Ingredient in Decades

How the new FDA-approved ingredient bemotrizinol enhances sunscreen protection

Report: FDA just launched a study on the abortion pill

« KAIST to produce 'Janus-faced' nanomaterials... Paving the way for new materials to selectively capture radioactive pollutants - EurekAlert!

Americans split on fluoridation; opposition by MAHA supporters notable - EurekAlert! »